
Omeros
Tarveda Therapeutics takes a novel approach to cancer treatment
| Headquarter | 134 Coolidge Avenue Watertown, MA United States of America |
|---|---|
| Website | www.tarveda.com/ |
| Founding Date | 2012 |
| Tel | (617)923-4100 |
| Company Status | Private |

Drew Fromkin CEO / President
Drew Fromkin serves as the CEO / President of Tarveda Therapeutics.

Laura Mei Vice President, Clinical Operations
Laura Mei serves as the Vice President, Clinical Operations of Tarveda Therapeutics. Laura started at Tarveda...

Michael Metzger Member Board Of Directors
Michael Metzger serves as the Member Board Of Directors of Tarveda Therapeutics. Michael started at Tarveda Therapeutics...

Jeffrey Bloss Chief Medical Officer
Jeffrey Bloss serves as the Chief Medical Officer of Tarveda Therapeutics. Jeffrey started at Tarveda Therapeutics in...

Mark Bilodeau Executive Vice President, Drug Discovery
Mark Bilodeau serves as the Executive Vice President, Drug Discovery of Tarveda Therapeutics. Mark currently resides in...

Sudha Kadiyala SVP Strategy & Development
Sudha Kadiyala serves as the SVP Strategy & Development of Tarveda Therapeutics. Sudha currently resides in the Greater...

Omid Farokhzad Founder and Director
Omid Farokhzad serves as the Founder and Director of Tarveda Therapeutics. Omid currently resides in the San Francisco...

Drew Fromkin Chief Executive Officer, Chairman
Drew Fromkin serves as the Chief Executive Officer, Chairman of Tarveda Therapeutics.

Brian Roberts Chief Financial Officer
Brian Roberts serves as the Chief Financial Officer of Tarveda Therapeutics.

No Recent Jobs found for Tarveda Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Tarveda Therapeutics address?
Tarveda Therapeutics location is at 134 Coolidge Avenue
Who are Tarveda Therapeutics competitors?
Tarveda Therapeutics main competitors are Omeros
Who is Tarveda Therapeutics leadership?
Laura Mei, Michael Metzger & Jeffrey Bloss are part of Tarveda Therapeutics leadership, Drew Fromkin is the CEO